WEBVTT
Kind: captions
Language: en

00:00:00.000 --> 00:00:03.010 

so<00:00:00.690> thousand<00:00:01.140> and<00:00:01.260> 80<00:00:01.380> cases<00:00:01.680> were<00:00:02.010> identified

00:00:03.010 --> 00:00:03.020 
so thousand and 80 cases were identified

00:00:03.020 --> 00:00:06.980 
so thousand and 80 cases were identified
550<00:00:04.020> where<00:00:04.140> AM<00:00:04.380> L<00:00:04.560> sandforce<00:00:05.009> permission<00:00:05.990> 535

00:00:06.980 --> 00:00:06.990 
550 where AM L sandforce permission 535

00:00:06.990 --> 00:00:10.040 
550 where AM L sandforce permission 535
or<00:00:07.230> MDS<00:00:07.649> data<00:00:08.429> came<00:00:08.730> from<00:00:08.760> 89<00:00:09.179> centers<00:00:09.840> from

00:00:10.040 --> 00:00:10.050 
or MDS data came from 89 centers from

00:00:10.050 --> 00:00:12.259 
or MDS data came from 89 centers from
around<00:00:10.290> the<00:00:10.530> world<00:00:10.679> this<00:00:11.400> is<00:00:11.460> truly<00:00:12.059> an

00:00:12.259 --> 00:00:12.269 
around the world this is truly an

00:00:12.269 --> 00:00:15.049 
around the world this is truly an
international<00:00:12.599> effort<00:00:13.490> the<00:00:14.490> results<00:00:14.910> were

00:00:15.049 --> 00:00:15.059 
international effort the results were

00:00:15.059 --> 00:00:17.750 
international effort the results were
compared<00:00:15.750> in<00:00:15.900> four<00:00:16.109> different<00:00:16.260> groups<00:00:16.760> we

00:00:17.750 --> 00:00:17.760 
compared in four different groups we

00:00:17.760 --> 00:00:19.689 
compared in four different groups we
analyzed<00:00:18.270> transferred<00:00:19.109> related<00:00:19.470> mortality

00:00:19.689 --> 00:00:19.699 
analyzed transferred related mortality

00:00:19.699 --> 00:00:22.880 
analyzed transferred related mortality
relapse<00:00:20.699> sprayed<00:00:21.029> from<00:00:21.689> the<00:00:21.990> final<00:00:22.380> leukemia

00:00:22.880 --> 00:00:22.890 
relapse sprayed from the final leukemia

00:00:22.890 --> 00:00:24.590 
relapse sprayed from the final leukemia
free<00:00:23.039> survival<00:00:23.340> in<00:00:23.670> patients<00:00:23.820> according<00:00:24.300> to

00:00:24.590 --> 00:00:24.600 
free survival in patients according to

00:00:24.600 --> 00:00:28.370 
free survival in patients according to
whether<00:00:24.810> they<00:00:24.990> were<00:00:25.050> 42<00:00:25.980> 54<00:00:26.580> years<00:00:26.760> old<00:00:27.109> 55<00:00:28.109> to

00:00:28.370 --> 00:00:28.380 
whether they were 42 54 years old 55 to

00:00:28.380 --> 00:00:31.999 
whether they were 42 54 years old 55 to
59<00:00:28.710> years<00:00:29.099> old<00:00:29.330> 62<00:00:30.330> 64<00:00:30.840> years<00:00:31.080> old<00:00:31.230> for<00:00:31.740> greater

00:00:31.999 --> 00:00:32.009 
59 years old 62 64 years old for greater

00:00:32.009 --> 00:00:36.740 
59 years old 62 64 years old for greater
than<00:00:32.130> 65<00:00:32.759> years<00:00:32.969> of<00:00:33.030> age<00:00:34.790> surprisingly<00:00:35.790> the

00:00:36.740 --> 00:00:36.750 
than 65 years of age surprisingly the

00:00:36.750 --> 00:00:38.990 
than 65 years of age surprisingly the
transplant<00:00:37.260> related<00:00:37.620> mortality<00:00:37.800> the<00:00:38.610> relapse

00:00:38.990 --> 00:00:39.000 
transplant related mortality the relapse

00:00:39.000 --> 00:00:41.630 
transplant related mortality the relapse
rate<00:00:39.300> in<00:00:39.690> the<00:00:39.809> leukemia<00:00:40.230> free<00:00:40.379> survival<00:00:40.680> were

00:00:41.630 --> 00:00:41.640 
rate in the leukemia free survival were

00:00:41.640 --> 00:00:44.139 
rate in the leukemia free survival were
similar<00:00:42.180> in<00:00:42.329> all<00:00:42.600> groups<00:00:42.899> regardless<00:00:43.590> of<00:00:43.739> age

00:00:44.139 --> 00:00:44.149 
similar in all groups regardless of age

00:00:44.149 --> 00:00:46.729 
similar in all groups regardless of age
and<00:00:45.149> when<00:00:45.270> the<00:00:45.300> multivariate<00:00:45.989> analysis<00:00:46.559> was

00:00:46.729 --> 00:00:46.739 
and when the multivariate analysis was

00:00:46.739 --> 00:00:50.450 
and when the multivariate analysis was
done<00:00:47.239> only<00:00:48.239> disease<00:00:48.989> stage<00:00:49.350> and<00:00:49.739> donor

00:00:50.450 --> 00:00:50.460 
done only disease stage and donor

00:00:50.460 --> 00:00:52.939 
done only disease stage and donor
matching<00:00:51.050> resulted<00:00:52.050> in<00:00:52.230> important

00:00:52.939 --> 00:00:52.949 
matching resulted in important

00:00:52.949 --> 00:00:55.639 
matching resulted in important
prognostic<00:00:53.129> factors<00:00:53.879> for<00:00:54.030> outcomes<00:00:54.649> this

00:00:55.639 --> 00:00:55.649 
prognostic factors for outcomes this

00:00:55.649 --> 00:00:58.459 
prognostic factors for outcomes this
allows<00:00:56.010> us<00:00:56.039> to<00:00:56.280> conclude<00:00:56.930> that<00:00:57.930> for<00:00:58.199> older

00:00:58.459 --> 00:00:58.469 
allows us to conclude that for older

00:00:58.469 --> 00:01:00.529 
allows us to conclude that for older
patients<00:00:58.649> with<00:00:59.280> a<00:00:59.309> few<00:00:59.579> myelogenous<00:00:59.879> leukemia

00:01:00.529 --> 00:01:00.539 
patients with a few myelogenous leukemia

00:01:00.539 --> 00:01:03.619 
patients with a few myelogenous leukemia
a<00:01:00.750> mile<00:01:01.289> dysplastic<00:01:01.649> syndrome<00:01:02.280> our<00:01:03.149> genetic

00:01:03.619 --> 00:01:03.629 
a mile dysplastic syndrome our genetic

00:01:03.629 --> 00:01:05.000 
a mile dysplastic syndrome our genetic
trans<00:01:03.840> men<00:01:04.049> with<00:01:04.199> the<00:01:04.290> reduced<00:01:04.559> intensity

00:01:05.000 --> 00:01:05.010 
trans men with the reduced intensity

00:01:05.010 --> 00:01:07.370 
trans men with the reduced intensity
regimen<00:01:05.549> will<00:01:06.210> result<00:01:06.600> in<00:01:06.750> long-term<00:01:06.930> disease

00:01:07.370 --> 00:01:07.380 
regimen will result in long-term disease

00:01:07.380 --> 00:01:10.580 
regimen will result in long-term disease
control<00:01:07.979> and<00:01:08.159> probably<00:01:08.939> cure<00:01:09.270> it<00:01:10.200> should<00:01:10.470> be

00:01:10.580 --> 00:01:10.590 
control and probably cure it should be

00:01:10.590 --> 00:01:13.250 
control and probably cure it should be
considered<00:01:11.130> a<00:01:11.340> valid<00:01:12.180> therapeutic<00:01:12.780> strategy

00:01:13.250 --> 00:01:13.260 
considered a valid therapeutic strategy

00:01:13.260 --> 00:01:15.499 
considered a valid therapeutic strategy
for<00:01:13.619> these<00:01:13.799> patients<00:01:14.010> and<00:01:14.939> that<00:01:15.090> age<00:01:15.270> should

00:01:15.499 --> 00:01:15.509 
for these patients and that age should

00:01:15.509 --> 00:01:16.820 
for these patients and that age should
no<00:01:15.689> longer<00:01:15.720> be<00:01:16.080> considered<00:01:16.350> a

00:01:16.820 --> 00:01:16.830 
no longer be considered a

00:01:16.830 --> 00:01:18.649 
no longer be considered a
contraindication<00:01:17.610> prowl<00:01:18.210> genetic

00:01:18.649 --> 00:01:18.659 
contraindication prowl genetic

00:01:18.659 --> 00:01:21.260 
contraindication prowl genetic
transplant<00:01:19.140> in<00:01:19.320> this<00:01:19.650> population<00:01:20.150> we<00:01:21.150> also

00:01:21.260 --> 00:01:21.270 
transplant in this population we also

00:01:21.270 --> 00:01:23.870 
transplant in this population we also
think<00:01:21.540> that<00:01:21.720> this<00:01:21.840> further<00:01:22.520> should<00:01:23.520> support

00:01:23.870 --> 00:01:23.880 
think that this further should support

00:01:23.880 --> 00:01:27.140 
think that this further should support
the<00:01:24.119> use<00:01:24.330> of<00:01:24.540> or<00:01:25.170> the<00:01:25.229> coverage<00:01:25.860> of<00:01:26.150> our

00:01:27.140 --> 00:01:27.150 
the use of or the coverage of our

00:01:27.150 --> 00:01:28.999 
the use of or the coverage of our
genetic<00:01:27.360> transplant<00:01:28.080> for<00:01:28.470> patients<00:01:28.770> from<00:01:28.860> all

00:01:28.999 --> 00:01:29.009 
genetic transplant for patients from all

00:01:29.009 --> 00:01:30.800 
genetic transplant for patients from all
this<00:01:29.159> plastic<00:01:29.369> syndrome<00:01:29.939> in<00:01:30.150> the<00:01:30.479> United

00:01:30.800 --> 00:01:30.810 
this plastic syndrome in the United

00:01:30.810 --> 00:01:33.260 
this plastic syndrome in the United
States<00:01:31.020> how<00:01:31.829> widespread<00:01:32.159> in<00:01:32.579> countries<00:01:33.060> where

00:01:33.260 --> 00:01:33.270 
States how widespread in countries where

00:01:33.270 --> 00:01:35.149 
States how widespread in countries where
reimbursement<00:01:34.049> isn't<00:01:34.290> an<00:01:34.380> issue<00:01:34.500> and

00:01:35.149 --> 00:01:35.159 
reimbursement isn't an issue and

00:01:35.159 --> 00:01:37.480 
reimbursement isn't an issue and
widespread<00:01:35.640> is<00:01:36.150> their<00:01:36.420> reluctance<00:01:36.930> to

00:01:37.480 --> 00:01:37.490 
widespread is their reluctance to

00:01:37.490 --> 00:01:42.200 
widespread is their reluctance to
undertake<00:01:38.659> HCT<00:01:39.659> in<00:01:39.930> older<00:01:40.470> patients<00:01:41.060> that<00:01:42.060> is

00:01:42.200 --> 00:01:42.210 
undertake HCT in older patients that is

00:01:42.210 --> 00:01:45.039 
undertake HCT in older patients that is
an<00:01:42.299> excellent<00:01:42.509> question<00:01:42.750> if<00:01:43.259> you<00:01:43.409> take<00:01:43.649> aside

00:01:45.039 --> 00:01:45.049 
an excellent question if you take aside

00:01:45.049 --> 00:01:48.679 
an excellent question if you take aside
resource<00:01:46.049> availability<00:01:46.799> and<00:01:47.100> and<00:01:47.689> payment

00:01:48.679 --> 00:01:48.689 
resource availability and and payment

00:01:48.689 --> 00:01:51.710 
resource availability and and payment
issues<00:01:49.020> I<00:01:49.350> think<00:01:50.189> the<00:01:50.549> reluctance<00:01:51.119> is<00:01:51.360> based

00:01:51.710 --> 00:01:51.720 
issues I think the reluctance is based

00:01:51.720 --> 00:01:54.319 
issues I think the reluctance is based
on<00:01:52.020> physician<00:01:52.710> perceptions<00:01:53.430> about<00:01:53.670> toxicity

00:01:54.319 --> 00:01:54.329 
on physician perceptions about toxicity

00:01:54.329 --> 00:01:59.410 
on physician perceptions about toxicity
and<00:01:56.090> the<00:01:57.090> reason<00:01:57.270> i<00:01:57.420> think<00:01:57.659> this<00:01:57.810> study<00:01:58.110> is

00:01:59.410 --> 00:01:59.420 
and the reason i think this study is

00:01:59.420 --> 00:02:01.969 
and the reason i think this study is
important<00:02:00.420> one<00:02:00.990> of<00:02:01.110> the<00:02:01.170> reasons<00:02:01.500> i<00:02:01.619> think<00:02:01.860> the

00:02:01.969 --> 00:02:01.979 
important one of the reasons i think the

00:02:01.979 --> 00:02:04.580 
important one of the reasons i think the
study<00:02:02.219> is<00:02:02.399> important<00:02:02.939> is<00:02:03.450> because<00:02:03.509> it<00:02:04.079> dispels

00:02:04.580 --> 00:02:04.590 
study is important is because it dispels

00:02:04.590 --> 00:02:08.089 
study is important is because it dispels
that<00:02:04.920> notion<00:02:05.780> acute<00:02:06.780> leukemia<00:02:07.320> in<00:02:07.740> order

00:02:08.089 --> 00:02:08.099 
that notion acute leukemia in order

00:02:08.099 --> 00:02:11.330 
that notion acute leukemia in order
patients<00:02:08.610> or<00:02:08.789> mdf<00:02:09.450> virus<00:02:09.989> disease<00:02:10.379> as

00:02:11.330 --> 00:02:11.340 
patients or mdf virus disease as

00:02:11.340 --> 00:02:12.890 
patients or mdf virus disease as
median<00:02:11.580> life<00:02:11.730> expectancy<00:02:12.420> of<00:02:12.450> less<00:02:12.569> than<00:02:12.840> a

00:02:12.890 --> 00:02:12.900 
median life expectancy of less than a

00:02:12.900 --> 00:02:15.619 
median life expectancy of less than a
year<00:02:13.050> and<00:02:13.170> a<00:02:13.200> half<00:02:13.430> so<00:02:14.430> these<00:02:14.640> disease<00:02:15.120> even

00:02:15.619 --> 00:02:15.629 
year and a half so these disease even

00:02:15.629 --> 00:02:17.839 
year and a half so these disease even
with<00:02:15.870> modern<00:02:16.080> therapy<00:02:16.800> outside<00:02:17.700> of

00:02:17.839 --> 00:02:17.849 
with modern therapy outside of

00:02:17.849 --> 00:02:19.520 
with modern therapy outside of
transplantation<00:02:18.420> are<00:02:18.840> stealing<00:02:19.470> our

00:02:19.520 --> 00:02:19.530 
transplantation are stealing our

00:02:19.530 --> 00:02:22.190 
transplantation are stealing our
patients<00:02:20.040> an<00:02:20.129> enormous<00:02:20.550> amount<00:02:20.849> of<00:02:20.940> time<00:02:21.200> so

00:02:22.190 --> 00:02:22.200 
patients an enormous amount of time so

00:02:22.200 --> 00:02:24.110 
patients an enormous amount of time so
this<00:02:22.349> at<00:02:22.530> least<00:02:22.709> gives<00:02:23.220> them<00:02:23.459> the<00:02:23.610> option<00:02:23.760> of

00:02:24.110 --> 00:02:24.120 
this at least gives them the option of

00:02:24.120 --> 00:02:26.680 
this at least gives them the option of
you<00:02:24.390> know<00:02:24.510> curative<00:02:25.260> therapy<00:02:25.739> which<00:02:25.980> can

00:02:26.680 --> 00:02:26.690 
you know curative therapy which can

00:02:26.690 --> 00:02:29.360 
you know curative therapy which can
extensively<00:02:27.690> expand<00:02:28.349> their<00:02:28.560> you<00:02:29.250> know<00:02:29.280> their

00:02:29.360 --> 00:02:29.370 
extensively expand their you know their

00:02:29.370 --> 00:02:32.539 
extensively expand their you know their
reproductive<00:02:30.299> life<00:02:30.569> so<00:02:31.410> the<00:02:31.830> fact<00:02:32.069> that<00:02:32.160> you

00:02:32.539 --> 00:02:32.549 
reproductive life so the fact that you

00:02:32.549 --> 00:02:34.789 
reproductive life so the fact that you
know<00:02:32.700> you<00:02:32.760> were<00:02:33.299> more<00:02:33.810> experienced<00:02:34.349> than<00:02:34.560> life

00:02:34.789 --> 00:02:34.799 
know you were more experienced than life

00:02:34.799 --> 00:02:37.100 
know you were more experienced than life
shouldn't<00:02:35.549> detract<00:02:35.790> you<00:02:36.060> from<00:02:36.390> being<00:02:36.780> able<00:02:36.900> to

00:02:37.100 --> 00:02:37.110 
shouldn't detract you from being able to

00:02:37.110 --> 00:02:40.700 
shouldn't detract you from being able to
get<00:02:37.260> a<00:02:37.290> therapy<00:02:37.680> of<00:02:37.799> potentially<00:02:38.310> curative

